¹⁷⁷Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: Biokinetics, Dosimetry, and Evaluation in Patients with Advanced Prostate Cancer

Figure 5

Treatment response evaluated using the ⁶⁸Ga-iPSMA-PET/CT diagnostic images (upper images) after three cycles with ¹⁷⁷Lu-iPSMA (bottom: images at 24 h after the first cycle and 6 d after the second cycle with ¹⁷⁷Lu-iPSMA) (patient 1, complete response).